SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is trending as a high-volatility short squeeze play, with traders closely monitoring its exceptionally low float and rising borrow rates that are forcing shorts to cover positions. The community is actively debating the stock's potential to reach triple-digit prices, while balancing excitement for parabolic gains against warnings of impending dilution and the risks of a sharp reversal.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is currently trending as investors weigh strong earnings beats and positive long-term product milestones against concerns over shareholder dilution and a large executive compensation package. The community is sharply divided between bulls focusing on the production ramp of the R2 SUV and bears warning about ongoing cash burn and the potential for capital raises.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy is actively discussing a potential turnaround and rotation back into the MULN crypto token, with community members coordinating to revive momentum despite significant skepticism from traders who draw parallels between these crypto movements and past controversies involving the underlying company.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox stock is facing significant volatility following a sharp post-earnings sell-off, with investors expressing intense polarization over the company's growth deceleration, mounting regulatory and child-safety concerns, and the long-term viability of its engagement metrics. While some community members see the depressed valuation as a deep-value buying opportunity for a long-term recovery, others are actively shorting the stock, citing management's guidance cuts and persistent structural challenges as signs of a weakening platform.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its identity as a global cannabis culture project on the Solana blockchain, emphasizing long-term growth and cultural alignment over short-term speculation. Participants are actively discussing its potential for dispensary utility and long-term ecosystem development while preparing for upcoming culture-focused events.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors react to a powerful earnings report that showcased record cloud revenue growth and robust AI integration, driving shares to all-time highs. The market is currently fixated on whether the company's aggressive AI infrastructure spending will continue to translate into sustainable, high-margin revenue growth compared to its mega-cap peers.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending following a significant earnings beat and positive guidance, which has fueled a sharp post-market rally and helped catalyze a broader recovery in sentiment for the enterprise software sector. The community is actively debating whether this performance marks a sustainable turnaround for SaaS companies or a temporary relief rally amid ongoing concerns about AI-driven disruption.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is trending as investors react to preliminary fourth-quarter revenue results that exceeded expectations and signaled a potential recovery from recent growth concerns. While the stock initially surged following the guidance, the community remains divided, with active debates centered on whether this rally marks a sustainable turnaround or an opportunity to play volatility amidst lingering skepticism regarding the company's long-term management and market competition.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing significant social media buzz driven by a blowout earnings report that shattered analyst expectations for revenue and user growth. Community discussion is heavily focused on the stock's potential for a short squeeze, with many users highlighting strong monetization trends and the platform's unique value in the AI data licensing space.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently trending as investors weigh an impressive earnings beat against concerns over a significant increase in capital expenditure projected for AI infrastructure. The community remains deeply divided, with many traders viewing the stock's sharp decline as a buying opportunity for a long-term leader, while others express frustration over the company's aggressive spending and potential impact on near-term profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down

SNY misses Q2 earnings and sales estimates but lifts 2025 sales outlook on strong Dupixent and vaccine momentum.

Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High?

The mean of analysts' price targets for Vigil Neuroscience (VIGL) points to a 26.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet

Should You Buy Vigil Neuroscience, Inc. (VIGL) After Golden Cross?

Wall Street Analysts Believe Vigil Neuroscience (VIGL) Could Rally 86.68%: Here's is How to Trade

Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

French pharmaceutical major Sanofi SA (SNY) said on Thursday that it would acquire U.S.-based Vigil Neuroscience, Inc. (VIGL) for about $470 million.Vigil is a clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases. The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-21-23-15-31-3086232">said</a> the acquisition will allow Sanofi to expand its neurology pipeline.The acquisition also includes Vigil’s investigational medicine VG-3927, which is being evaluated in the treatment of Alzheimer’s disease.However, Sanofi will not acquire Vigil’s second molecule program, VGL101, being studied in patients with a rare neurodegenerative disease called Leukoencephalopathy.Under the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing. This represents a 246% premium to Vigil’s closing price of $2.31 on Wednesday.Vigil’s shareholders will also receive a non-transferable contingent value right (CVR) per Vigil share, which will entitle its holder to a deferred cash payment of $2 upon the first commercial sale of VG-3927.The companies expect the transaction to close in the third quarter (Q3) of 2025, subject to customary closing conditions. The deal is not expected to have an impact on Sanofi’s financial guidance for 2025.On Stocktwits, retail sentiment around Vigil jumped from ‘bearish’ to ‘extremely bullish’ over the past 24 hours while message volume jumped from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:624/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_22_at_8_39_32_AM_png_8f74f85395.webp" alt="VIGL's Sentiment Meter and Message Volume as of 8:45 a.m. ET on May 22, 2025 | Source: Stocktwits" width="624" height="61"><figcaption>VIGL's Sentiment Meter and Message Volume as of 8:45 a.m. ET on May 22, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/VIGL">VIGL stock</a> was up about 242% in pre-market trading on Thursday. The stock has gained 31% this year but has fallen over 37% over the past 12 months.Nasdaq-listed shares of <a href="https://stocktwits.com/symbol/SNY">Sanofi</a>, meanwhile, are up by about 10% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/advance-auto-parts-report-upbeat-q1-earnings/ch099tRRbp1">Advance Auto Parts Stock Soars Pre-market On Upbeat Q1 Earnings: Retail Expects Rally Toward $45 Mark</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish

Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing.

Equity

Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing.


Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.

VIGL
Vigil Neuroscience Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VIGL News

VIGLVigil Neuroscience Inc